Maxigen Biotech (Taiwan) Buy Hold or Sell Recommendation
| 1783 Stock | TWD 43.70 0.50 1.13% |
Assuming the 90 days trading horizon and your above-average risk tolerance, our recommendation regarding Maxigen Biotech is 'Cautious Hold'. A buy or sell recommendation provided by Macroaxis is an automated directive regarding whether to purchase or sell Maxigen Biotech given historical horizon and risk tolerance towards Maxigen Biotech. When Macroaxis issues a 'buy' or 'sell' recommendation for Maxigen Biotech, the advice is generated through an automated system that utilizes algorithms and statistical models.
Check out Maxigen Biotech Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. Note, we conduct extensive research on individual companies such as Maxigen and provide practical buy, sell, or hold advice based on investors' constraints. Maxigen Biotech. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.
Maxigen |
Execute Maxigen Biotech Buy or Sell Advice
The Maxigen recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on Maxigen Biotech. Macroaxis does not own or have any residual interests in Maxigen Biotech or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute Maxigen Biotech's advice using the current market data and latest reported fundamentals.
Time Horizon
Risk Tolerance
 |  |
Cautious Hold
Market Performance | Very Weak | Details | |
Volatility | Very steady | Details | |
Hype Condition | Stale | Details | |
Current Valuation | Fairly Valued | Details | |
Odds Of Distress | Low | Details | |
Economic Sensitivity | Slowly supersedes the market | Details | |
Analyst Consensus | Not Available | Details | |
Reporting Quality (M-Score) | Inapplicable | Details |
Maxigen Biotech Trading Alerts and Improvement Suggestions
| Maxigen Biotech generated a negative expected return over the last 90 days | |
| About 52.0% of the company shares are owned by insiders or employees |
Maxigen Biotech Returns Distribution Density
The distribution of Maxigen Biotech's historical returns is an attempt to chart the uncertainty of Maxigen Biotech's future price movements. The chart of the probability distribution of Maxigen Biotech daily returns describes the distribution of returns around its average expected value. We use Maxigen Biotech price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of Maxigen Biotech returns is essential to provide solid investment advice for Maxigen Biotech.
| Mean Return | -0.06 | Value At Risk | -2.32 | Potential Upside | 2.61 | Standard Deviation | 1.24 |
Return Density |
| Distribution |
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of Maxigen Biotech historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.
Maxigen Biotech Greeks
Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to Maxigen Biotech or Healthcare sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that Maxigen Biotech's price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a Maxigen stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α | Alpha over Dow Jones | -0.1 | |
β | Beta against Dow Jones | 0.27 | |
σ | Overall volatility | 1.26 | |
Ir | Information ratio | -0.15 |
Maxigen Biotech Volatility Alert
Maxigen Biotech exhibits very low volatility with skewness of 0.76 and kurtosis of 2.37. Understanding different market volatility trends often help investors to time the market. Properly using volatility indicators enable traders to measure Maxigen Biotech's stock risk against market volatility during both bullish and bearish trends. The higher level of volatility that comes with bear markets can directly impact Maxigen Biotech's stock price while adding stress to investors as they watch their shares' value plummet. This usually forces investors to rebalance their portfolios by buying different financial instruments as prices fall.Maxigen Biotech Fundamentals Vs Peers
Comparing Maxigen Biotech's fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze Maxigen Biotech's direct or indirect competition across all of the common fundamentals between Maxigen Biotech and the related equities. This way, we can detect undervalued stocks with similar characteristics as Maxigen Biotech or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of Maxigen Biotech's fundamental indicators could also be used in its relative valuation, which is a method of valuing Maxigen Biotech by comparing valuation metrics with those of similar companies.
| Better Than Average | Worse Than Average | Compare Maxigen Biotech to competition |
| Fundamentals | Maxigen Biotech | Peer Average |
| Return On Equity | 0.0926 | -0.31 |
| Return On Asset | 0.0454 | -0.14 |
| Profit Margin | 0.19 % | (1.27) % |
| Operating Margin | 0.16 % | (5.51) % |
| Current Valuation | 3.32 B | 16.62 B |
| Shares Outstanding | 84.7 M | 571.82 M |
| Shares Owned By Insiders | 51.89 % | 10.09 % |
| Shares Owned By Institutions | 2.28 % | 39.21 % |
| Price To Earning | 33.55 X | 28.72 X |
| Price To Book | 3.24 X | 9.51 X |
| Price To Sales | 6.63 X | 11.42 X |
| Revenue | 511.98 M | 9.43 B |
| Gross Profit | 261.03 M | 27.38 B |
| EBITDA | 130.56 M | 3.9 B |
| Net Income | 87.67 M | 570.98 M |
| Cash And Equivalents | 390.34 M | 2.7 B |
| Cash Per Share | 5.62 X | 5.01 X |
| Total Debt | 16.62 M | 5.32 B |
| Debt To Equity | 1.50 % | 48.70 % |
| Current Ratio | 7.81 X | 2.16 X |
| Book Value Per Share | 14.75 X | 1.93 K |
| Cash Flow From Operations | 117.59 M | 971.22 M |
| Earnings Per Share | 1.23 X | 3.12 X |
| Number Of Employees | 20 | 18.84 K |
| Beta | 1.05 | -0.15 |
| Market Capitalization | 5.02 B | 19.03 B |
| Total Asset | 1.27 B | 29.47 B |
| Retained Earnings | (14 M) | 9.33 B |
| Working Capital | 560 M | 1.48 B |
| Current Asset | 623 M | 9.34 B |
| Current Liabilities | 63 M | 7.9 B |
| Annual Yield | 0.02 % | |
| Net Asset | 1.27 B |
Maxigen Biotech Market Momentum
Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as Maxigen . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
| Accumulation Distribution | 17987.98 | |||
| Daily Balance Of Power | (0.23) | |||
| Rate Of Daily Change | 0.99 | |||
| Day Median Price | 44.7 | |||
| Day Typical Price | 44.37 | |||
| Price Action Indicator | (1.25) | |||
| Period Momentum Indicator | (0.50) | |||
| Relative Strength Index | 50.76 |
About Maxigen Biotech Buy or Sell Advice
When is the right time to buy or sell Maxigen Biotech? Buying financial instruments such as Maxigen Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.
Use Investing Ideas to Build Portfolios
In addition to having Maxigen Biotech in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Momentum Thematic Idea Now
Momentum
Large corporations operating in software, education, financial and car manufacturing industries. The Momentum theme has 40 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Momentum Theme or any other thematic opportunities.
| View All Next | Launch |
Additional Tools for Maxigen Stock Analysis
When running Maxigen Biotech's price analysis, check to measure Maxigen Biotech's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Maxigen Biotech is operating at the current time. Most of Maxigen Biotech's value examination focuses on studying past and present price action to predict the probability of Maxigen Biotech's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Maxigen Biotech's price. Additionally, you may evaluate how the addition of Maxigen Biotech to your portfolios can decrease your overall portfolio volatility.